Loading…
NS Products, Inc. was cited for marketing NaturaCure as a drug without FDA approval by making disease treatment claims on their website, including unsubstantiated assertions that the product could treat infertility disorders such as ovarian cysts, uterine fibroids, endometriosis, and PCOS, and could achieve pregnancy rates up to 98%. The company violated the Federal Food, Drug, and Cosmetic Act by introducing a product into interstate commerce with claims establishing its intended use for curing, mitigating, treating, or preventing disease without proper drug approval or authorization. The FDA and Federal Trade Commission jointly reviewed the company's website (naturacure.net) in March and May 2021, respectively, identifying these violations.